Clinical trial
AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung…
NCT00343408 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00343408 |
|---|---|
| Title | AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal Cancer |
| Official title | A Phase I, Open-Label, Dose-Seeking Study of AZD2171 Given Daily Orally in Combination With Selected Standard Chemotherapy Regimens (CT) in Patients With Advanced Incurable Non-Small Cell Lung Cancer (NSCLC) or Colorectal Cancer |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Lung Cancer |
| Intervention type | Drug |
| Interventions | cediranib maleate, cisplatin, fluorouracil, gemcitabine hydrochloride, leucovorin calcium, oxaliplatin |
| Enrollment | 31 |
| Start date | Nov 29, 2005 |
| Primary completion | Sep 18, 2007 |
| Completion | Sep 22, 2008 |
| First posted | Jun 23, 2006 |
| Last update posted | Aug 4, 2023 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: